BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 13, 2008
View Archived Issues
Nucleoside reverse transcriptase inhibitor active in mouse AIDS model
Read More
Antiretroviral compound may have distinct mechanism of action
Read More
Reduction of CSF biomarkers with PBT-2 treatment in phase II study
Read More
MyD88 deficiency associated with rare pyogenic bacterial infections in children
Read More
Vertex offers Q2 overview
Read More
Cannabinoid receptor 1 identified as colorectal cancer target
Read More
Oxycyte in development as gel for surface wounds
Read More
Acrux and KV sign expanded agreement for Evamist and other products
Read More
Peregrine initiates patient screening and dosing in phase II trial of bavituximab
Read More
PhytoMedical acquires worldwide license rights to Dartmouth's novel anticancer compounds
Read More
Starpharma initiates clinical trial to measure level of antiviral activity retained by VivaGel
Read More
Sanofi-aventis exercises option for expanded access to ImmunoGen's TAP technology
Read More
FDA accepts Pain Therapeutics' NDA for Remoxy and grants priority review
Read More
SF-1019 approved in Malaysia
Read More
NCI initiates enrollment in phase II clinical trial of Reolysin
Read More
Shire: Q2 update
Read More
MedImmune initiates phase IIa clinical trial of Medarex's MEDI-545 in SLE
Read More
Canopus Biopharma reports positive results from mouse study of StatC in H5N1, H1N1 and H3N2
Read More
Cerus is granted CE mark for Intercept in treatment of previously frozen plasma
Read More
New agents for metabolic disorders described in recent patents
Read More
New analgesic agents revealed in recent patents
Read More
Recent patents describe novel agents for asthma, allergy, etc.
Read More